Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Roivant Sciences Ltd (NASDAQ: ROIV) closed the day trading at $10.44 down -2.52% from the previous closing price of $10.71. In other words, the price has decreased by -$2.52 from its previous closing price. On the day, 4.04 million shares were traded. ROIV stock price reached its highest trading level at $10.8 during the session, while it also had its lowest trading level at $10.425.
Ratios:
For a better understanding of ROIV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.77 and its Current Ratio is at 27.79. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On January 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $14.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 09 ’24 when Venker Eric sold 96,950 shares for $10.92 per share. The transaction valued at 1,058,694 led to the insider holds 532,207 shares of the business.
Ramaswamy Vivek sold 3,000,000 shares of ROIV for $33,150,000 on Jan 02 ’24. The 10% Owner now owns 51,929,426 shares after completing the transaction at $11.05 per share. On Oct 05 ’23, another insider, Venker Eric, who serves as the Chief Operating Officer of the company, sold 153,027 shares for $10.11 each. As a result, the insider received 1,547,103 and left with 595,397 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 8413031936 and an Enterprise Value of 2743620352. As of this moment, Roivant’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.00. For the stock, the TTM Price-to-Sale (P/S) ratio is 68.27 while its Price-to-Book (P/B) ratio in mrq is 1.38. Its current Enterprise Value per Revenue stands at 22.262 whereas that against EBITDA is -2.676.
Stock Price History:
The Beta on a monthly basis for ROIV is 1.31, which has changed by 0.18636358 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, ROIV has reached a high of $13.24, while it has fallen to a 52-week low of $7.60. The 50-Day Moving Average of the stock is -4.47%, while the 200-Day Moving Average is calculated to be -1.88%.
Shares Statistics:
Over the past 3-months, ROIV traded about 7.41M shares per day on average, while over the past 10 days, ROIV traded about 5481300 shares per day. A total of 760.14M shares are outstanding, with a floating share count of 552.92M. Insiders hold about 31.39% of the company’s shares, while institutions hold 50.49% stake in the company. Shares short for ROIV as of 1711584000 were 30925011 with a Short Ratio of 4.17, compared to 1709164800 on 27691602. Therefore, it implies a Short% of Shares Outstanding of 30925011 and a Short% of Float of 7.199999999999999.
